Infection by verocytotoxin-producing Escherichia coli
- PMID: 2644022
- PMCID: PMC358098
- DOI: 10.1128/CMR.2.1.15
Infection by verocytotoxin-producing Escherichia coli
Abstract
Verocytotoxin (VT)-producing Escherichia coli (VTEC) are a newly recognized group of enteric pathogens which are increasingly being recognized as common causes of diarrhea in some geographic settings. Outbreak studies indicate that most patients with VTEC infection develop mild uncomplicated diarrhea. However, a significant risk of two serious and potentially life-threatening complications, hemorrhagic colitis and the hemolytic uremic syndrome, makes VTEC infection a public health problem of serious concern. The main reservoirs of VTEC appear to be the intestinal tracts of animals, and foods of animal (especially bovine) origin are probably the principal sources for human infection. The term VT refers to a family of subunit exotoxins with high biological activity. Individual VTEC strains elaborate one or both of at least two serologically distinct, bacteriophage-mediated VTs (VT1 and VT2) which are closely related to Shiga toxin and are thus also referred to as Shiga-like toxins. The holotoxins bind to cells, via their B subunits, to a specific receptor which is probably the glycolipid, globotriosyl ceramide (Gb3). Binding is followed by internalization of the A subunit, which, after it is proteolytically nicked and reduced to the A1 fragment, inhibits protein synthesis in mammalian cells by inactivating 60S ribosomal subunits through selective structural modification of 28S ribosomal ribonucleic acid. The mechanism of VTEC diarrhea is still controversial, and the relative roles of locally acting VT and "attaching and effacing adherence" of VTEC to the mucosa have yet to be resolved. There is increasing evidence that hemolytic uremic syndrome and possibly hemorrhagic colitis result from the systemic action of VT on vascular endothelial cells. The role of antitoxic immunity in preventing the systemic complications of VTEC infection is being explored. Antibiotics appear to be contraindicated in the treatment of VTEC infection. The most common VTEC serotype associated with human disease is O157:H7, but over 50 different VT-positive O:H serotypes have now been identified. The best strategies for diagnosing human VTEC infection include testing for the presence of free VT in fecal filtrates and examining fecal cultures for VTEC by means of deoxyribonucleic acid probes that specify genes encoding VT1 and VT2. Both methods are currently confined to specialized laboratories and await commercial development for wider use. In the meantime, most laboratories should continue to screen for the most common human VTEC serotype, O157:H7, using a sorbitol-containing MacConkey medium.
Similar articles
-
Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals.Vet Res. 1999 Mar-Jun;30(2-3):235-57. Vet Res. 1999. PMID: 10367357 Review.
-
Detection of verocytotoxin from stool and serological testing of patients with diarrhea caused by Escherichia coli O157 : H7.Microbiol Immunol. 1993;37(2):111-8. doi: 10.1111/j.1348-0421.1993.tb03187.x. Microbiol Immunol. 1993. PMID: 8502176
-
Virulence factors and phenotypical traits of verotoxigenic strains of Escherichia coli isolated from human patients in Germany.Med Microbiol Immunol. 1994 Feb;183(1):13-21. doi: 10.1007/BF00193627. Med Microbiol Immunol. 1994. PMID: 8202027
-
Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.Arch Dis Child. 1990 Jul;65(7):722-7. doi: 10.1136/adc.65.7.722. Arch Dis Child. 1990. PMID: 2201262 Free PMC article.
-
Applications of DNA probes for Vero cytotoxin-producing Escherichia coli.J Hosp Infect. 1991 Jun;18 Suppl A:438-42. doi: 10.1016/0195-6701(91)90054-c. J Hosp Infect. 1991. PMID: 1679813 Review.
Cited by
-
Small fibre neuropathy in Fabry disease: a human-derived neuronal in vitro disease model and pilot data.Brain Commun. 2024 Apr 3;6(2):fcae095. doi: 10.1093/braincomms/fcae095. eCollection 2024. Brain Commun. 2024. PMID: 38638148 Free PMC article.
-
Bacteriological evaluation and advanced SYBR-green multiplex real-time PCR assay for detection of minced meat adulteration.Open Vet J. 2024 Jan;14(1):389-397. doi: 10.5455/OVJ.2024.v14.i1.35. Epub 2024 Jan 31. Open Vet J. 2024. PMID: 38633161 Free PMC article.
-
Genomic island-encoded regulatory proteins in enterohemorrhagic Escherichia coli O157:H7.Virulence. 2024 Dec;15(1):2313407. doi: 10.1080/21505594.2024.2313407. Epub 2024 Feb 15. Virulence. 2024. PMID: 38357901 Free PMC article. Review.
-
First report of the prevalence of Shiga toxinproducing Escherichia coli in ground beef in Quindío, Colombia.Biomedica. 2023 Dec 1;43(4):474-482. doi: 10.7705/biomedica.7004. Biomedica. 2023. PMID: 38109140 Free PMC article.
-
Efficacy of EHEC gold nanoparticle vaccines evaluated with the Shiga toxin-producing Citrobacter rodentium mouse model.Microbiol Spectr. 2024 Jan 11;12(1):e0226123. doi: 10.1128/spectrum.02261-23. Epub 2023 Dec 4. Microbiol Spectr. 2024. PMID: 38047703 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical